Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | melanin-concentrating hormone receptor 1 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.0217 | 0.0217 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0025 | 0.0333 | 0.0333 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0.0147 | 0.5 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0019 | 0.0037 | 0.0114 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0021 | 0.0147 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.1741 | 0.1741 |
Echinococcus multilocularis | zinc finger protein | 0.0021 | 0.0153 | 0.0153 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.1741 | 0.1741 |
Brugia malayi | PHD-finger family protein | 0.0027 | 0.0477 | 0.0979 |
Schistosoma mansoni | zinc finger protein | 0.0021 | 0.0153 | 0.0153 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.1741 | 0.1741 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0022 | 0.0217 | 0.0667 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.3256 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.1437 | 0.4413 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0.0147 | 0.5 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.0147 | 0.5 |
Brugia malayi | Bromodomain containing protein | 0.0042 | 0.1289 | 0.3391 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0025 | 0.0333 | 0.0333 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.1741 | 0.1741 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0021 | 0.0147 | 0.5 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0065 | 0.2587 | 0.2587 |
Toxoplasma gondii | exonuclease III APE | 0.0021 | 0.0147 | 0.5 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0021 | 0.0147 | 0.0451 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0039 | 0.1145 | 0.1145 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0021 | 0.0147 | 0.5 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0025 | 0.0333 | 0.0333 |
Schistosoma mansoni | hypothetical protein | 0.0198 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.0147 | 0.0147 |
Echinococcus granulosus | zinc finger protein | 0.0021 | 0.0153 | 0.0153 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0039 | 0.1145 | 0.1145 |
Schistosoma mansoni | hypothetical protein | 0.0198 | 1 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0021 | 0.0147 | 0.5 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0021 | 0.0147 | 0.5 |
Echinococcus multilocularis | geminin | 0.0198 | 1 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0065 | 0.2587 | 0.2587 |
Schistosoma mansoni | bromodomain containing protein | 0.0069 | 0.2805 | 0.2805 |
Brugia malayi | Bromodomain containing protein | 0.0082 | 0.3516 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.1553 | 0.4769 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.005 | 0.1741 | 0.4731 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0021 | 0.0147 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.1293 | 0.3972 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0.0147 | 0.5 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.0147 | 0.0147 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0021 | 0.0147 | 0.0147 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.1741 | 0.1741 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0021 | 0.0147 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.1741 | 0.1741 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0021 | 0.0147 | 0.0147 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.0147 | 0.5 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.0147 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.005 | 0.1741 | 0.5346 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.0147 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.1741 | 0.1741 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 7.2 nM | BindingDB_Patents: Binding Assay. Evaluation of the affinity of compounds for the human MCH-1 receptor was accomplished using 4-(3,4,5-tritritiumbenzyloxy)-1-(1-(2-(pyrrolidin-1-yl)ethyl)-1H-indazol-5-yl)pyridin-2(1H)-one and membranes prepared from stable CHO-K1 cells expressing the human MCH-1 receptor obtained from Euroscreen (Batch 1138). Cell membrane homogenates (8.92 µg protein) were incubated for 60 min at 25° C. with 1.4 nM of the [3H]-labeled compound in the absence or presence of the test compound in 50 mM Tris-HCl buffer, pH 7.4. Nonspecific binding was determined in the presence of 50 µM 1-(5-(4-cyanophenyl)bicyclo[3.1.0]hexan-2-yl)-3-(4-fluoro-3-(trifluoromethyl)phenyl)-1-(3-(4-methylpiperazin-1-yl)propyl)urea. Following incubation, the samples were filtered rapidly under vacuum through Skatron 11731 filters, pre-soaked in 0.5% polyethylenimine, and washed with ice-cold 50 mM Tris-HCl buffer, pH 7.4, (wash setting 9,9,0) using a Skatron cell harvester. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.